CIAM
GRI

Caitong International Asset Management’s GRI Bio GRI Stock Holding History

Caitong International Asset Management’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Buy
+2
New +$4 ﹤0.01% 2765

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Caitong International Asset Management's GRI Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in GRI Bio (GRI) in Q2 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #2765 among its holdings.

8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Caitong International Asset Management held 2 shares of GRI Bio worth $4 as of Q2 2026.
  • GRI Bio was a new Caitong International Asset Management position in Q2 2026.
  • GRI Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2765 holding.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.